Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 29, 2022 9:00 AM 4 min read

Collaboration and Innovation to Be Featured at Advarra's 2022 Onsemble Customer Conference

by PRNewswire
Follow

Conference brings together key leaders from clinical research sites, sponsors, and CROs, transforming clinical research with a site-centric technology approach

COLUMBIA, Md., March 29, 2022 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions, clinical site technologies, and research quality and compliance consulting services, today welcomed over 1,300 attendees to its Onsemble 2022 customer conference, the premier clinical research community event. Taking place March 29 to April 1 at the Westin Savannah Harbor Golf Resort & Spa in Savannah, GA, the event will be delivered both in-person and virtually. The conference provides research site attendees unmatched opportunities to learn, to network with key site, sponsor and CRO stakeholders, and to collaborate on technology solutions that will shape the future of clinical research.

The conference begins with the first in-person meeting of Advarra's recently announced Site-Sponsor Consortium. Leading site, sponsor, CRO, and data standards representatives are gathering to find opportunities to seamlessly connect site and sponsor technology in order to solve longstanding process and workflow challenges. The group aims to take a site-centric, patient-focused approach to solving these challenges faced by the clinical research industry with the aim of bringing treatments to market safer and more efficiently.

"Successful collaboration across stakeholders requires standards that provide a common language to support interoperability and sharing," said Rhonda Facile, VP, Partnerships and Development at CDISC. "CDISC looks forward to working with the Site-Sponsor Consortium to optimize and standardize workflows across the research industry utilizing CDISC standards and governance."

About Advarra

SOURCE Advarra

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Press Releases
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter

"Onsemble is an invaluable opportunity to collaborate with industry thought-leaders and explore innovative ways to expand access to clinical research," said Sharmila Bristol, Chief Technology Officer at Javara. "We look forward to gaining new insights through participating in Advarra's interactive sessions, networking with colleagues, and collaborating with industry stakeholders as part of the Site-Sponsor Consortium. It is a privilege to be presenting on the Integrated Research Organization and the synergistic value it brings to healthcare as a part of this year's meeting as well."

The Onsemble conference will showcase the latest Advarra technology product innovations as well as perspectives from leading clinical research organizations including Javara, University of Florida, St. Jude, Stanford Medicine, and Duke School of Medicine. Attendees will be able to participate in more than 40 sessions covering site-centric topics such as financial and regulatory management, diversity and inclusion, training and adoption, clinical trials office (CTO) leadership, and much more.

"Our Onsemble Community members are at the forefront of innovation in clinical research and provide a vital connection to participants," said Jonathan E. Shough, President of Advarra Technology Solutions. "We're thrilled to work with our community to address the biggest challenges in the industry, working to do more with less, taking on increasingly complex trials, and creating a more connected industry to make research safer, smarter, and faster."

Leading sites are represented at the conference, with attendees ranging from clinical trials office leadership, clinical research coordinators, data managers, and regulatory managers, as well as those representing financial management, clinical informatics, and biostatistics teams. Attendees will have opportunities to earn continuing education units (CEUs) from ACRP, California Board of Nursing, PRIM&R, and SOCRA throughout the week.

Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.

Comments
Loading...